[
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Softer Late Afternoon",
    "summary": "Health care stocks declined late Thursday afternoon with the NYSE Health Care Index and the Health C",
    "url": "https://finnhub.io/api/news?id=4917d2d9bc9b7224b02d3ecba954d37cb32fa3fd29efcf6972f39f52d51e1e43",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763672010,
      "headline": "Sector Update: Health Care Stocks Softer Late Afternoon",
      "id": 137566589,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Health care stocks declined late Thursday afternoon with the NYSE Health Care Index and the Health C",
      "url": "https://finnhub.io/api/news?id=4917d2d9bc9b7224b02d3ecba954d37cb32fa3fd29efcf6972f39f52d51e1e43"
    }
  },
  {
    "ts": null,
    "headline": "Moderna to onshore drug product manufacturing to Massachusetts",
    "summary": "The initiative forms part of Moderna’s continued investment in US-based infrastructure.",
    "url": "https://finnhub.io/api/news?id=8e1c508184fdfcbdbf4b94fee806c0e0068c97ca67c697affcc98a6ae4b23d68",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763650448,
      "headline": "Moderna to onshore drug product manufacturing to Massachusetts",
      "id": 137556908,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The initiative forms part of Moderna’s continued investment in US-based infrastructure.",
      "url": "https://finnhub.io/api/news?id=8e1c508184fdfcbdbf4b94fee806c0e0068c97ca67c697affcc98a6ae4b23d68"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Trims Pipeline and Takes On $1.5 Billion Loan as Cash Worries Loom",
    "summary": "Moderna’s nearly $20 billion cash hoard has dwindled to a single-digit stash following a series of setbacks for the biotech.",
    "url": "https://finnhub.io/api/news?id=76eec4e5ea214152238d9871951c219e579b88083eb20af0f8c0c5326fb99fe0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763650260,
      "headline": "Moderna Trims Pipeline and Takes On $1.5 Billion Loan as Cash Worries Loom",
      "id": 137556909,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna’s nearly $20 billion cash hoard has dwindled to a single-digit stash following a series of setbacks for the biotech.",
      "url": "https://finnhub.io/api/news?id=76eec4e5ea214152238d9871951c219e579b88083eb20af0f8c0c5326fb99fe0"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management",
    "summary": "Non-dilutive financing from premier lender bolsters strong balance sheet and provides increased flexibility Company reiterates 2025 financial guidance provided on 3Q25 earnings call and targets cash breakeven by 2028 CAMBRIDGE, MA / ACCESS Newswire ...",
    "url": "https://finnhub.io/api/news?id=d13d3b31220fdca9e8da10363aa964e2b5d51ed5f8f503e6f0bb07e6d8c9795e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763640000,
      "headline": "Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management",
      "id": 137556911,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Non-dilutive financing from premier lender bolsters strong balance sheet and provides increased flexibility Company reiterates 2025 financial guidance provided on 3Q25 earnings call and targets cash breakeven by 2028 CAMBRIDGE, MA / ACCESS Newswire ...",
      "url": "https://finnhub.io/api/news?id=d13d3b31220fdca9e8da10363aa964e2b5d51ed5f8f503e6f0bb07e6d8c9795e"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates",
    "summary": "Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to expand seasonal vaccine franchise from three to up to six approved products by 2028 Targets readouts from nine ongoing Phase ...",
    "url": "https://finnhub.io/api/news?id=629e1fbba4badfd501d8d937f6ef02af5c2147d622bade0d13d99a23de91b209",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763640000,
      "headline": "Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates",
      "id": 137556910,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to expand seasonal vaccine franchise from three to up to six approved products by 2028 Targets readouts from nine ongoing Phase ...",
      "url": "https://finnhub.io/api/news?id=629e1fbba4badfd501d8d937f6ef02af5c2147d622bade0d13d99a23de91b209"
    }
  },
  {
    "ts": null,
    "headline": "Moderna secures $1.5B lifeline as it looks to break even in 2028",
    "summary": "At an analyst day event, Moderna said it wants to invest revenue from a hopefully expanded seasonal vaccine franchise into oncology and rare disease programs, to “set the stage for additional growth in 2027 and 2028.”",
    "url": "https://finnhub.io/api/news?id=c93b4c9d07b9b10654beffe5a2066d3c7a56b941aaa4f5c482306ba016a35f49",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763639580,
      "headline": "Moderna secures $1.5B lifeline as it looks to break even in 2028",
      "id": 137563283,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "At an analyst day event, Moderna said it wants to invest revenue from a hopefully expanded seasonal vaccine franchise into oncology and rare disease programs, to “set the stage for additional growth in 2027 and 2028.”",
      "url": "https://finnhub.io/api/news?id=c93b4c9d07b9b10654beffe5a2066d3c7a56b941aaa4f5c482306ba016a35f49"
    }
  }
]